MPN: The Molecular Drivers of Disease Initiation, Progression and Transformation and their Effect on Treatment
Myeloproliferative neoplasms (MPNs) constitute a group of disorders identified by an overproduction of cells derived from myeloid lineage. The majority of MPNs have an identifiable driver mutation responsible for cytokine-independent proliferative signalling. The acquisition of coexisting mutations...
Main Authors: | Julian Grabek, Jasmin Straube, Megan Bywater, Steven W. Lane |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/8/1901 |
Similar Items
-
Remodeling the Bone Marrow Microenvironment – A Proposal for Targeting Pro-inflammatory Contributors in MPN
by: Jonas Samuel Jutzi, et al.
Published: (2020-08-01) -
Experimental Modeling of Myeloproliferative Neoplasms
by: Lucie Lanikova, et al.
Published: (2019-10-01) -
A Broad Overview of Signaling in <i>Ph</i>-Negative Classic Myeloproliferative Neoplasms
by: Ana Guijarro-Hernández, et al.
Published: (2021-02-01) -
Molecular Genetic Markers and Clinical Characteristics of Essential Thrombocythemia
by: AA Zhernyakova, et al.
Published: (2017-07-01) -
Clinical features of essential thrombocythemia and primary myelofibrosis, depending on the molecular characteristics of disease
by: A L Melikyan, et al.
Published: (2017-07-01)